NewsWatch: After months of speculation, investors get excited about Pfizer, BioNTech’s coronavirus vaccine candidate

This post was originally published on this site

The path to a COVID-19 vaccine has started to come into view this week, following the stock-moving disclosures of preliminary clinical data for two candidates and a rigorous new regulatory road map from the Food and Drug Administration.

Add Comment